Benjamin E. Gewurz

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 Regulation.
  2019 L1 No data access

1 assessed by us (0 reproduced) · 165 not yet assessed — every PubMed paper on record, linked below.

• Systematic investigation reveals extensive Epstein-Barr virus transcriptional regulation of the human genome ↗

  Cell Genomics · 2026 · PMID 40766721
  not yet assessed
• Epstein-barr virus latent membrane protein 1 targets cIAP1, cIAP2 and TRAF2 for proteasomal degradation to activate the non-canonical NF-κB pathway ↗

  PLoS Pathogens · 2026 · PMID 41587214
  not yet assessed
• Epstein-Barr Virus Latent Membrane Protein 1 Suppresses Ferroptosis via Pentose Phosphate Pathway and Glutathione Metabolism ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2026 · PMID 41959453
  not yet assessed
• P-2180. Evaluation of Cytomegalovirus Resistance at an Academic Medical Center ↗

  Open Forum Infectious Diseases · 2026
  not yet assessed
• A tonsil organoid model reveals Epstein-Barr virus infected germinal center B cell states during primary infection ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2026 · PMID 41648427
  not yet assessed
• EBNA1 INHIBITORS REVEAL CDC7 AND POU2F1 AS DIRECT FUNCTIONAL TARGETS IN EBV EPITHELIAL CANCERS ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2026
  not yet assessed
• Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV-associated gastric cancer ↗

  mBio · 2026 · PMID 41665354
  not yet assessed
• Anellovirus-Mediated Interferon Dysregulation Enhances Virus-Induced Lung Injury ↗

  American Journal of Respiratory Cell and Molecular Biology · 2026 · PMID 42089290
  not yet assessed
• A CRISPR-Cas9 screen Reveals STEEP1 as a Key Host Dependency Factor for Epstein-Barr Virus Latent Membrane Protein 1 Trafficking and Signaling ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2026 · PMID 41890102
  not yet assessed
• CRISPR Screens Reveal Epstein-Barr Virus-activated JunB as a Key Lymphoblastoid B cell Dependency Factor that Represses Cyclin Dependent Kinase Inhibitor P18INK4c ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2026 · PMID 41959378
  not yet assessed
• Epstein-Barr virus orchestrates spatial reorganization and immunomodulation in the classic Hodgkin lymphoma tumor microenvironment ↗

  Cell Reports Medicine · 2026 · PMID 41923627
  not yet assessed
• EBNA1 inhibitors reveal CDC7 and POU2F1 as direct functional targets in EBV epithelial cancers ↗

  mBio · 2026 · PMID 42132380
  not yet assessed
• The HUSH Complex Dictates EBV-transformed B cell Sensitivity to NK Cell Surveillance Through Repression of NKG2A Ligand γ-Proto-cadherin ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2026
  not yet assessed
• Arginine metabolism supports <i>de novo</i> pyrimidine biosynthesis to block DNA damage and maintain Epstein-Barr virus latency ↗

  mBio · 2026 · PMID 42294882
  not yet assessed
• Epigenetic Regulation of the Epstein–Barr Virus Latent–Lytic Switch ↗

  Journal of Medical Virology · 2026 · PMID 42345494
  not yet assessed
• Epstein-Barr virus transformation creates a methionine-dependent ferroptosis vulnerability in B cells ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2026 · PMID 42523280
  not yet assessed
• SLE risk variants shapes IRF5 alternative promoter isoform usage in B cells 2252005 ↗

  The Journal of Immunology · 2026
  not yet assessed
• Variant-to-function mapping in lupus links <i>IL12A</i> to the expansion of disease-associated B cells with a cytotoxic program ↗

  medRxiv · 2026
  not yet assessed
• TGFβ links EBV to multisystem inflammatory syndrome in children ↗

  Nature · 2025 · PMID 40074901
  not yet assessed
• Epstein-Barr Virus Exposure Precedes Crohn's Disease Development ↗

  Gastroenterology · 2025 · PMID 40010579
  not yet assessed
• Lysine-specific histone demethylase complex restricts Epstein–Barr virus lytic reactivation ↗

  Nature Microbiology · 2025 · PMID 41174223
  not yet assessed
• Epstein–Barr virus exploits desmocollin 2 as the principal epithelial cell entry receptor ↗

  Nature Microbiology · 2025 · PMID 41006833
  not yet assessed
• Epstein–Barr virus BALF0/1 subverts the Caveolin and ERAD pathways to target B cell receptor complexes for degradation ↗

  Proceedings of the National Academy of Sciences · 2025 · PMID 39847318
  not yet assessed
• Epstein-Barr virus latent membrane protein 1 subverts IMPDH pathways to drive B-cell oncometabolism ↗

  PLoS Pathogens · 2025 · PMID 40367275
  not yet assessed
• Multiomic analysis reveals a key BCAT1 role in mTOR activation by B cell receptor and TLR9 ↗

  Journal of Clinical Investigation · 2025 · PMID 40924473
  not yet assessed
• MUC1-C auto-regulatory complex with EBNA1 is responsible for latent Epstein-Barr virus-associated gastric cancer progression ↗

  Oncogene · 2025 · PMID 40764753
  not yet assessed
• Viral oncogene EBNALP regulates YY1 DNA binding and alters host 3D genome organization ↗

  EMBO Reports · 2025 · PMID 39747661
  not yet assessed
• The CTLH ubiquitin ligase substrates ZMYND19 and MKLN1 negatively regulate mTORC1 at the lysosomal membrane ↗

  Nature Communications · 2025 · PMID 41315365
  not yet assessed
• The Histone Demethylase LSD1/ZNF217/CoREST Complex is a Major Restriction Factor of Epstein-Barr Virus Lytic Reactivation ↗

  Research Square · 2025 · PMID 39877093
  not yet assessed
• Epstein-Barr Virus Encoded lncRNAs Control the Viral Lytic Switch ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2025 · PMID 41279497
  not yet assessed
• A multi-omics resource of B cell activation reveals genetic mechanisms for immune-mediated diseases ↗

  medRxiv · 2025 · PMID 40475139
  not yet assessed
• Integrated transcriptomic and methylome analysis reveals retinoic acid pathway activation after decitabine treatment in EBV associated gastric cancer ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2025 · PMID 41280003
  not yet assessed
• Insights into the Absence of Lymphoma Despite Fulminant Epstein-Barr Virus Infection in Patients with XIAP Deficiency ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2025 · PMID 39868266
  not yet assessed
• Insights into absence of lymphoma despite fulminant Epstein-Barr virus infection in patients with XIAP deficiency ↗

  JCI Insight · 2025 · PMID 40674368
  not yet assessed
• Epstein-Barr Virus Latent Membrane Protein 1 targets cIAP1, cIAP2 and TRAF2 for Proteasomal Degradation to Activate the Non-canonical NF-κB Pathway ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2025 · PMID 40950096
  not yet assessed
• Arginine Metabolism Supports <i>De Novo</i> Pyrimidine Biosynthesis to Block DNA Damage and Maintain Epstein-Barr Virus Latency ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2025 · PMID 41279143
  not yet assessed
• EBV infection and immune response dynamics in human tonsil organoids 4366 ↗

  The Journal of Immunology · 2025
  not yet assessed
• Research landmarks on the 60th anniversary of Epstein-Barr virus ↗

  Science China Life Sciences · 2024 · PMID 39505801
  not yet assessed
• The nucleic acid binding protein SFPQ represses EBV lytic reactivation by promoting histone H1 expression ↗

  Nature Communications · 2024 · PMID 38755141
  not yet assessed
• Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression ↗

  PLoS Pathogens · 2024 · PMID 38683861
  not yet assessed
• Multifaceted roles for STAT3 in gammaherpesvirus latency revealed through <i>in vivo</i> B cell knockout models ↗

  mBio · 2024 · PMID 38170993
  not yet assessed
• Efficient CRISPR/Cas9 Knock‐in Approaches for Manipulation of Endogenous Genes in Human B Lymphoma Cells ↗

  Current Protocols · 2024 · PMID 39535522
  not yet assessed
• The DNA loop release factor WAPL suppresses Epstein-Barr virus latent membrane protein expression to maintain the highly restricted latency I program ↗

  PLoS Pathogens · 2024 · PMID 39241017
  not yet assessed
• The CTLH Ubiquitin Ligase Substrates ZMYND19 and MKLN1 Negatively Regulate mTORC1 at the Lysosomal Membrane ↗

  Research Square · 2024 · PMID 38746323
  not yet assessed
• Germinal Center Cytokines Driven Epigenetic Control of Epstein-Barr Virus Latency Gene Expression ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2024 · PMID 38260430
  not yet assessed
• Epstein-Barr Virus Orchestrates Spatial Reorganization and Immunomodulation within the Classic Hodgkin Lymphoma Tumor Microenvironment ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2024 · PMID 38496566
  not yet assessed
• Multi-omic Analysis of Human B-cell Activation Reveals a Key Lysosomal BCAT1 Role in mTOR Hyperactivation by B-cell receptor and TLR9 ↗

  Research Square · 2024 · PMID 38854072
  not yet assessed
• The DNA loop release factor WAPL suppresses Epstein-Barr virus latent membrane protein expression to maintain the highly restricted latency I program ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2024 · PMID 38766209
  not yet assessed
• Epstein-Barr Virus Latent Membrane Protein 1 Subverts IMPDH pathways to drive B-cell oncometabolism ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2024 · PMID 39574729
  not yet assessed
• Epstein–Barr Virus BALF0/1 Subverts the Caveolin and ERAD Pathways to Target B-cell Receptor Complexes for Degradation ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2024
  not yet assessed
• Elliott Dan Kieff, MD, PhD (1943–2024) ↗

  Cell · 2024 · PMID 38608648
  not yet assessed
• Elliott Dan Kieff (1943 to 2024): Epstein–Barr virus cancer biology pioneer ↗

  Proceedings of the National Academy of Sciences · 2024 · PMID 38950365
  not yet assessed
• Germline-encoded amino acid–binding motifs drive immunodominant public antibody responses ↗

  Science · 2023 · PMID 37023193
  not yet assessed
• An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation ↗

  Molecular Cell · 2023 · PMID 37311461
  not yet assessed
• Treatment for First Cytomegalovirus Infection Post–Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir ↗

  Clinical Infectious Diseases · 2023 · PMID 38036487
  not yet assessed
• A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth ↗

  Nature Communications · 2023 · PMID 36949074
  not yet assessed
• Characterization of target gene regulation by the two Epstein-Barr virus oncogene LMP1 domains essential for B-cell transformation ↗

  mBio · 2023 · PMID 38009935
  not yet assessed
• Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer ↗

  mBio · 2023 · PMID 37606370
  not yet assessed
• Cytokine receptor <i>IL27RA</i> is an NF-κB–responsive gene involved in CD38 upregulation in multiple myeloma ↗

  Blood Advances · 2023 · PMID 36867577
  not yet assessed
• Characterization of Target Gene Regulation by the Two Epstein-Barr Virus Oncogene LMP1 Domains Essential for B-cell Transformation ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2023 · PMID 37090591
  not yet assessed
• Data from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Data from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Table S2 from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Supplementary Figures from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Supplementary Figures from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Table S2 from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Table S6 from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Table S4 from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Table S3 from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Table S1 from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Table S5 from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Table S3 from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Table S4 from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Table S5 from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Table S1 from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Table S7 from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Table S6 from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Table S7 from Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  2023
  not yet assessed
• Methionine metabolism controls the B cell EBV epigenome and viral latency ↗

  Cell Metabolism · 2022 · PMID 36070681
  not yet assessed
• Epstein–Barr virus latency programs dynamically sensitize B cells to ferroptosis ↗

  Proceedings of the National Academy of Sciences · 2022 · PMID 35275790
  not yet assessed
• Epstein-Barr virus BNRF1 destabilizes SMC5/6 cohesin complexes to evade its restriction of replication compartments ↗

  Cell Reports · 2022 · PMID 35263599
  not yet assessed
• Epstein–Barr virus oncoprotein–driven B cell metabolism remodeling ↗

  PLoS Pathogens · 2022 · PMID 35108325
  not yet assessed
• The Epstein-Barr Virus Enhancer Interaction Landscapes in Virus-Associated Cancer Cell Lines ↗

  Journal of Virology · 2022 · PMID 36094314
  not yet assessed
• The nuclear lamina binds the EBV genome during latency and regulates viral gene expression ↗

  PLoS Pathogens · 2022 · PMID 35421198
  not yet assessed
• Correction: Epstein–Barr virus oncoprotein–driven B cell metabolism remodeling ↗

  PLoS Pathogens · 2022 · PMID 36264852
  not yet assessed
• Methionine Metabolism Controls the B-cell EBV Epigenome and Viral Latency ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2022
  not yet assessed
• Author Correction: DNA methylation enzymes and PRC1 restrict B-cell Epstein–Barr virus oncoprotein expression ↗

  Nature Microbiology · 2022 · PMID 35505195
  not yet assessed
• Epstein-Barr virus latency programs dynamically sensitize B-cells to ferroptosis ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2022
  not yet assessed
• Abstract LB098: Integrative approaches to modulate antigen presentation and boost cancer immune response ↗

  Cancer Research · 2022
  not yet assessed
• Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade ↗

  Cancer Discovery · 2021 · PMID 33589424
  not yet assessed
• SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication ↗

  Nature Communications · 2021 · PMID 33723254
  not yet assessed
• N(6)-methyladenosine-binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay ↗

  EMBO Reports · 2021 · PMID 33605073
  not yet assessed
• Epigenetic control of the Epstein-Barr lifecycle ↗

  Current Opinion in Virology · 2021 · PMID 34891084
  not yet assessed
• EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein–Barr virus-associated gastric cancer ↗

  Gastric Cancer · 2021 · PMID 33929613
  not yet assessed
• Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-Cell Growth and Survival ↗

  mBio · 2021 · PMID 34281398
  not yet assessed
• Innate Immune Modulation Induced by EBV Lytic Infection Promotes Endothelial Cell Inflammation and Vascular Injury in Scleroderma ↗

  Frontiers in Immunology · 2021 · PMID 33953718
  not yet assessed
• CYB561A3 is the key lysosomal iron reductase required for Burkitt B-cell growth and survival ↗

  Blood · 2021 · PMID 34232987
  not yet assessed
• Abstract 65: Therapeutically increasing MHC-I expression potentiates immune checkpoint blockade ↗

  Cancer Research · 2021 · PMID 8132222
  not yet assessed
• Epstein-Barr Virus Induced Cytidine Metabolism Roles in Transformed B-cell Growth and Survival ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2021
  not yet assessed
• 700 Increasing MHC-I expression to potentiate immune checkpoint blockade therapy ↗

  Regular and Young Investigator Award Abstracts · 2021
  not yet assessed
• The Nuclear Lamina Binds the EBV Genome During Latency and Regulates Viral Gene Expression ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2021
  not yet assessed
• Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma ↗

  Cell Research · 2020 · PMID 32901110
  not yet assessed
• MYC Controls the Epstein-Barr Virus Lytic Switch ↗

  Molecular Cell · 2020 · PMID 32315601
  not yet assessed
• DNA methylation enzymes and PRC1 restrict B-cell Epstein–Barr virus oncoprotein expression ↗

  Nature Microbiology · 2020 · PMID 32424339
  not yet assessed
• CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells ↗

  Journal of Virology · 2020 · PMID 32238579
  not yet assessed
• Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy ↗

  Blood · 2020 · PMID 32157281
  not yet assessed
• Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation ↗

  mBio · 2020 · PMID 33109754
  not yet assessed
• Histone loaders CAF1 and HIRA restrict Epstein-Barr virus B-cell lytic reactivation ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2020
  not yet assessed
• Epstein-Barr-Virus-Induced One-Carbon Metabolism Drives B Cell Transformation ↗

  Cell Metabolism · 2019 · PMID 31257153
  not yet assessed
• RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes ↗

  Journal of Virology · 2019 · PMID 31019051
  not yet assessed
• Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival ↗

  PLoS Pathogens · 2019 · PMID 31518366
  not yet assessed
• CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 Regulation

  Cell Reports · 2019 · PMID 31365872
  L1 No data access
• TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity ↗

  Journal of Virology · 2019 · PMID 31167905
  not yet assessed
• Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma ↗

  Journal of Biological Chemistry · 2019 · PMID 31073033
  not yet assessed
• Epstein-Barr Virus Infection and Posttransplant Lymphoproliferative Disease ↗

  2019
  not yet assessed
• CRISPR/Cas9 Screens Reveal Multiple Layers of B Cell CD40 Regulation ↗

  SSRN Electronic Journal · 2019
  not yet assessed
• CRISPR/Cas9‐Mediated Genome Editing in Epstein‐Barr Virus‐Transformed Lymphoblastoid B‐Cell Lines ↗

  Current Protocols in Molecular Biology · 2018 · PMID 29337376
  not yet assessed
• CRISPR–Cas9 Genetic Analysis of Virus–Host Interactions ↗

  Viruses · 2018 · PMID 29385696
  not yet assessed
• Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300 ↗

  Journal of Virology · 2018 · PMID 29467311
  not yet assessed
• Epigenetic crossroads of the Epstein-Barr virus B-cell relationship ↗

  Current Opinion in Virology · 2018 · PMID 30227386
  not yet assessed
• Modulating Gene Expression in Epstein‐Barr Virus (EBV)‐Positive B Cell Lines with CRISPRa and CRISPRi ↗

  Current Protocols in Molecular Biology · 2018 · PMID 29337370
  not yet assessed
• Author Correction: Ephrin receptor A2 is an epithelial cell receptor for Epstein–Barr virus entry ↗

  Nature Microbiology · 2018 · PMID 29679064
  not yet assessed
• Regulation of checkpoint kinase signalling and tumorigenesis by the NF-κB regulated gene, CLSPN ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2018
  not yet assessed
• Raising the Barr: An Unexpected Lesion at Ileal–Cecal Resection ↗

  Digestive Diseases and Sciences · 2018 · PMID 30535887
  not yet assessed
• Ephrin receptor A2 is an epithelial cell receptor for Epstein–Barr virus entry ↗

  Nature Microbiology · 2017 · PMID 29292383
  not yet assessed
• Epstein-Barr Virus LMP1-Mediated Oncogenicity ↗

  Journal of Virology · 2017 · PMID 28835489
  not yet assessed
• CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors ↗

  Cell Host & Microbe · 2017 · PMID 28494239
  not yet assessed
• The Epstein-Barr Virus Regulome in Lymphoblastoid Cells ↗

  Cell Host & Microbe · 2017 · PMID 29024646
  not yet assessed
• A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells ↗

  Cell Reports · 2017 · PMID 28514666
  not yet assessed
• Mouse model of Epstein–Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease ↗

  Proceedings of the National Academy of Sciences · 2017 · PMID 28351978
  not yet assessed
• CRISPR/Cas9 Screens Reveal Requirements for Host Cell Sulfation and Fucosylation in Bacterial Type III Secretion System-Mediated Cytotoxicity ↗

  Cell Host & Microbe · 2016 · PMID 27453484
  not yet assessed
• A NOVEL PRIMARY IMMUNODEFICIENCY ASSOCIATED WITH EPSTEIN-BARR VIRUS SUCEPTIBILITY AND ASSOCIATED B-CELL MALIGNANCIES

  2016 CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference · 2016
  not yet assessed
• Epstein-Barr Virus Oncoprotein Super-enhancers Control B Cell Growth ↗

  Cell Host & Microbe · 2015 · PMID 25639793
  not yet assessed
• TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation ↗

  PLoS Pathogens · 2015 · PMID 25996949
  not yet assessed
• Evasion of affinity-based selection in germinal centers by Epstein–Barr virus LMP2A ↗

  Proceedings of the National Academy of Sciences · 2015 · PMID 26305967
  not yet assessed
• The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma ↗

  Oncogene · 2015 · PMID 26522720
  not yet assessed
• NF-κB subunits bind the EZH2 promoter in fibroblasts and B-cells. ↗

  Figshare · 2015
  not yet assessed
• NF-κB2 controls Rb phosphorylation, EZH2 expression and senescence through CDK4 and CDK6 regulation. ↗

  Figshare · 2015
  not yet assessed
• The NF-κB Genomic Landscape in Lymphoblastoid B Cells ↗

  Cell Reports · 2014 · PMID 25159142
  not yet assessed
• Regulation of p53 and Rb Links the Alternative NF-κB Pathway to EZH2 Expression and Cell Senescence ↗

  PLoS Genetics · 2014 · PMID 25255445
  not yet assessed
• Remodeling of the Intestinal Brush Border Underlies Adhesion and Virulence of an Enteric Pathogen ↗

  mBio · 2014 · PMID 25139905
  not yet assessed
• A Vibrio parahaemolyticus T3SS Effector Mediates Pathogenesis by Independently Enabling Intestinal Colonization and Inhibiting TAK1 Activation ↗

  Cell Reports · 2013 · PMID 23623501
  not yet assessed
• NF-κB and IRF7 Pathway Activation by Epstein-Barr Virus Latent Membrane Protein 1 ↗

  Viruses · 2013 · PMID 23793113
  not yet assessed
• Genome-wide siRNA screen for mediators of NF-κB activation ↗

  Proceedings of the National Academy of Sciences · 2012 · PMID 22308454
  not yet assessed
• Canonical NF-κB Activation Is Essential for Epstein-Barr Virus Latent Membrane Protein 1 TES2/CTAR2 Gene Regulation ↗

  Journal of Virology · 2011 · PMID 21543491
  not yet assessed
• Epstein–Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines ↗

  Proceedings of the National Academy of Sciences · 2010 · PMID 21173222
  not yet assessed
• Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-κB in the absence of NF-κB essential modifier residues 133–224 or 373–419 ↗

  Proceedings of the National Academy of Sciences · 2010 · PMID 20923877
  not yet assessed
• Human Babesiosis ↗

  Infectious Disease Clinics of North America · 2008 · PMID 18755385
  not yet assessed
• IRF7 activation by Epstein–Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3 ↗

  Proceedings of the National Academy of Sciences · 2008 · PMID 19017798
  not yet assessed
• Human herpesvirus 6 encephalitis ↗

  Current Infectious Disease Reports · 2008 · PMID 18765102
  not yet assessed
• Persistent and Relapsing Babesiosis in Immunocompromised Patients ↗

  Clinical Infectious Diseases · 2007 · PMID 18181735
  not yet assessed
• Herpesvirus evasion of T-cell immunity ↗

  Cambridge University Press eBooks · 2007
  not yet assessed
• DNA-Damage Control: Claspin Destruction Turns off the Checkpoint ↗

  Current Biology · 2006 · PMID 17084694
  not yet assessed
• HIV and the breast. ↗

  PubMed · 2005 · PMID 16110554
  not yet assessed
• Capravirine, a Nonnucleoside Reverse‐Transcriptase Inhibitor in Patients Infected with HIV‐1: A Phase 1 Study ↗

  The Journal of Infectious Diseases · 2004 · PMID 15529260
  not yet assessed
• US2, a Human Cytomegalovirus-encoded Type I Membrane Protein, Contains a Non-cleavable Amino-terminal Signal Peptide ↗

  Journal of Biological Chemistry · 2002 · PMID 11790769
  not yet assessed
• Human Cytomegalovirus US2 Endoplasmic Reticulum-Lumenal Domain Dictates Association with Major Histocompatibility Complex Class I in a Locus-Specific Manner ↗

  Journal of Virology · 2001 · PMID 11333901
  not yet assessed
• Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2 ↗

  Proceedings of the National Academy of Sciences · 2001 · PMID 11391001
  not yet assessed
• Virus subversion of immunity: a structural perspective ↗

  Current Opinion in Immunology · 2001 · PMID 11498300
  not yet assessed
• Viral Subversion of the Immune System ↗

  Annual Review of Immunology · 2000 · PMID 10837078
  not yet assessed
• B7 Costimulation Is Critical for Antibody Class Switching and CD8⁺Cytotoxic T-Lymphocyte Generation in the Host Response to Vesicular Stomatitis Virus ↗

  Journal of Virology · 2000 · PMID 10590107
  not yet assessed
• Down-regulation of MHC class I antigen presentation by HCMV; lessons for tumor immunology ↗

  Immunological Investigations · 2000 · PMID 10854174
  not yet assessed
• Either B7 Costimulation or IL-2 Can Elicit Generation of Primary Alloreactive CTL ↗

  The Journal of Immunology · 2000 · PMID 10975820
  not yet assessed
• Phenotypic switching of <i>Haemophilus influenzae</i> ↗

  Molecular Microbiology · 1996 · PMID 8830271
  not yet assessed
• Localization of sequence-determined neoepitopes and neutrophil digestion fragments of C-reactive protein utilizing monoclonal antibodies and synthetic peptides ↗

  Molecular Immunology · 1992 · PMID 1374844
  not yet assessed
• Reactivity of anti-human C-reactive protein (CRP) and serum amyloid P component (SAP) monoclonal antibodies with limulin and pentraxins of other species. ↗

  PubMed · 1992 · PMID 1378818
  not yet assessed